8.255USD+3.45%Mkt Cap: 648.40M USDP/E: 3.81Last update: 2026-05-26
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an an…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap648.40M USD
Enterprise Value601.65M USD
Revenue (TTM)400.05M USD
Gross Profit275.75M USD
Net Income (TTM)163.06M USD
Revenue/Share5.292 USD
Last Price8.255 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees191
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS21900C3088
Valuation
P/E (Trailing)3.81
P/E (Forward)23.03
PEG—
EV/EBITDA2.63
EV/Revenue1.50
P/S1.58
P/B1.45
EPS (TTM)2.17
EPS (Forward)0.35
52W Range
6.13019% of range17.43
52W High17.43 USD
52W Low6.130 USD
Profitability
Gross Margin88.46%
Oper. Margin49.96%
EBITDA Margin57.19%
Profit Margin52.31%
ROE40.23%
ROA19.74%
Growth
Revenue Growth226.10%
Earnings Growth42.80%
Cash Flow & Leverage
Operating CF175.05M USD
CapEx (TTM)2.26M USD
FCF Margin29.96%
FCF Yield18.48%
Net Debt-30.67M USD
Net Debt/EBITDA-0.13
Balance Sheet
Debt/Equity0.37
Current Ratio2.98
Quick Ratio2.58
Book Value/Sh5.575 USD
Cash/Share2.270 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 26, 2019
Splits
Last Split1:5
Split DateMar 26, 2019
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)15.00 USD
Target Range13.00 USD – 19.00 USD
# Analysts7
Ownership
Shares Out.78.45M
Float66.55M
Insiders7.51%
Institutions54.97%
Short Interest
Short Ratio16.0d
Short % Float20.96%
Short % Out.20.68%
Shares Short16.22M
Short (prev mo.)15.78M
Technical
SMA 507.248 (+13.9%)
SMA 2009.582 (-13.8%)
Beta1.46
S&P 52W Chg28.31%
Avg Vol (30d)1.25M
Avg Vol (10d)1.80M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—